Copyright 1994 The New York Times Company The New York Times April 10, 1994, Sunday, Late Edition – Final SECTION: Section 6; Page 50; Column 1; Magazine Desk LANGUAGE: ENGLISH LOAD-DATE-MDX: May 1, 1994 LENGTH: 2477 words HEADLINE: The Psychedelic Cure BYLINE: By Alexis Jetter THE OLD, WHITE HOTEL SOUTH…
Chicago Tribune March 22, 1994 Tuesday, EVENING UPDATE EDITION SECTION: NEWS; Pg. 7; ZONE: C; EVENING. Health. LANGUAGE: ENGLISH LOAD-DATE-MDX: April 10, 1994 LENGTH: 738 words HEADLINE: A DRUG TO FIGHT DRUGS BYLINE: By Sandra Blakeslee, New York Times News Service. BODY: Driven by a deep sense of frustration that…
Copyright 1993 Reuters, Limited November 16, 1993, Tuesday, BC cycle LENGTH: 380 words COLUMN: Health briefs LOAD-DATE: November 18, 1993 HEADLINE: AFRICAN ROOT STUDIED AS ADDICTION TREATMENT BYLINE: By Jane Sutton DATELINE: MIAMI BODY: An ancient and illegal hallucinogenic herb that was popular during the 1960s is under study as…
Copyright 1993 The New York Times Company The New York Times October 27, 1993, Wednesday, Late Edition – Final SECTION: Section C; Page 11; Column 1; Science Desk; Health Page LANGUAGE: ENGLISH LOAD-DATE-MDX: November 16, 1993 LENGTH: 1604 words HEADLINE: A Bizarre Drug Tested in the Hope of Helping Drug…
PSYCHEDELIC SCIENCE – Documentary by Bill Eagles Aired on: February 27th, 1997, BBC NARRATOR (HUGH QUARSHIE): Controversial human experiments with the psychedelic drug LSD held new promise for psychiatry in the 1950s. They were closed down when the drug was made illegal in 1966. Today a new generation of American scientists…
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
University of Miami’s Deborah Mash believes ibogaine could be the wonder drug to end all drugs. And she’s ready to risk everything to prove it. By Paula Park (Originally published in Miami New Times — 09.11.1997) Deborah Mash and her three colleagues from the University of Miami strolled into the…
Illegal in U.S., ibogaine advocates say it blocks withdrawal symptoms By Malcolm Ritter / Associated Press (2000) What if addiction, whether to cocaine, heroin or alcohol, could be broken by taking a single pill? That’s the audacious claim behind ibogaine, an extract of an African shrub. But don’t look for…
the Deborah Mash Interview with Paul DeRienzo Dr. Deborah Mash is a faculty member in the Department of Neurology of the University of Miami, School of Medicine with a secondary appointment in Cellular Molecular Pharmacology. Dr. Mash’s area of expertise is called Neuropharmacology and Neuroscience and her doctoral dissertation was…
By John Harrison, Psy.D. maps • volume xvi number 2 • Autumn 2006 The skies were a slippery gray and the air was wintry cold on the February weekend of the 2006 NYC Ibogaine Conference. The chilly weather, though, did not in any way inhibit the fervent and passionate panel…